Benefits
Brazilian folk medicine adaptogen tonic (heritage)
Pfaffia paniculata (Martius) Kuntze (also called Hebanthe eriantha or Hebanthe paniculata) — endemic Brazilian medicinal plant. AMARANTHACEAE family. Traditional uses: TONIC, INVIGORATING, ANTI-STRESS, APHRODISIAC, MEMORY IMPROVEMENT. Brazilian folk medicine 'anti-stress agent.' Distinguishing New World adaptogen heritage.
TNBS-induced intestinal anti-inflammatory (PMID 26202807)
Costa 2015 PMID 26202807 (Int Immunopharmacol 28:459-469) — TNBS-induced intestinal inflammation rat study. 200 mg/kg P. paniculata significantly DECREASED macroscopic damage score, lesion extension, colonic MPO activity. 25 mg/kg decreased Hsp70. Foundational anti-inflammatory IBD evidence — preclinical.
Mapk + mucin pathway intestinal modulation
Costa 2018 — P. paniculata extract modulates MAPK + MUCIN pathways in intestinal inflammation. Mechanism: signaling pathway regulation in colonic inflammation. Foundational mechanism extending TNBS rat anti-inflammatory evidence. Adaptogen + intestinal anti-inflammatory dual positioning.
Hepatocarcinogenesis preneoplastic lesions (Cancer Lett 2005)
Cancer Lett 2005 226:107-113 — P. paniculata inhibitory effects on PRENEOPLASTIC + NEOPLASTIC LESIONS in mouse hepatocarcinogenesis model. Foundational chemopreventive mechanism evidence. Cytotoxic effects on MCF-7 human breast cancer cells (Nagamine 2008). Preclinical anticancer signal.
β-Ecdysterone + saponins active compounds
Active compounds: β-ECDYSTERONE (phytosteroid — supports anabolic + adaptogen activity), SAPONINS, PFAFFIC ACIDS, NORTRITERPENES. β-ecdysterone induces osteogenic differentiation in MSCs + relieves osteoporosis (Gao). Suppresses IL-1β-induced apoptosis + inflammation in chondrocytes via NF-κB inhibition (Zhang 2014).
Antinociceptive glutamate + cytokine pathways
Freitas 2009 (J Ethnopharmacol 122:468-472) — P. glomerata antinociceptive effect involving glutamate + cytokine pathways in mice. Pain modulation mechanism. Foundational pain relief preclinical evidence supporting traditional analgesic + anti-inflammatory use.
HONEST limited human clinical evidence
HONEST framing: WebMD assessment — 'no good scientific evidence' for cancer, diabetes, male sexual performance, immune support claims. Studies on Pfaffia genera SCARCE compared to other 'ginsengs' (Panax, Eleutherococcus, Withania). MOST evidence preclinical (rats, mice, cell lines). HUMAN clinical trials LIMITED. Position cautiously.
Mechanism of action
β-Ecdysterone phytosteroid anabolic
β-Ecdysterone acts as phytosteroid with anabolic + adaptogen activity. Mechanism: estrogen receptor β binding + protein synthesis support. Distinguishing among adaptogens — phytosteroid mechanism.
MAPK + mucin pathway intestinal regulation
Costa 2018 — modulates MAPK + mucin pathways in intestinal inflammation. Mechanism: signaling pathway regulation supporting GI mucosal protection.
NF-κB MMP-9 inhibition (β-ecdysterone)
β-ecdysterone suppresses IL-1β-induced apoptosis + inflammation via NF-κB inhibition in chondrocytes (Zhang 2014). Mechanism: anti-inflammatory at cellular signaling level.
Antinociceptive glutamate + cytokine modulation
Freitas 2009 — pain modulation via glutamate + cytokine pathways (mice). Mechanism: analgesic activity supporting traditional anti-inflammatory tonic use.
Macrophage activity enhancement (Ehrlich tumor)
Matsuzaki 2003 — 200 mg/kg P. paniculata reduced Ehrlich ascitic tumor volume via increased macrophage activity. Mechanism: innate immune system activation supporting traditional 'tonic' positioning.
HPA axis adaptogen mechanism
Multi-target adaptogens enhance non-specific resistance to stressors via immune-neuro-endocrine system + HPA axis. Mechanism: foundational adaptogen framework — Pfaffia included in this category alongside Panax, Eleutherococcus, Withania.
Clinical trials
Animal study (Costa C et al. 2015, Int Immunopharmacol 28:459-469). UNESP Botucatu Phytomedicines Lab.
Rats with TNBS (trinitrobenzenesulfonic acid)-induced colonic inflammation. P. paniculata extract daily 14 days BEFORE or 7 days AFTER TNBS induction. Doses: 25, 50, 200 mg/kg + prednisolone control.
200 mg/kg P. paniculata significantly DECREASED macroscopic damage score, lesion extension, colonic MPO (myeloperoxidase) activity. 25 mg/kg decreased Hsp70 expression. Foundational anti-inflammatory IBD preclinical evidence supporting Brazilian folk 'anti-stress + tonic' adaptogen mechanism extension to gut inflammation.
Mouse hepatocarcinogenesis model study (Cancer Lett 2005, 226:107-113).
Mouse hepatocarcinogenesis model. P. paniculata roots extract administration. Preneoplastic + neoplastic lesion assessment.
INHIBITORY EFFECTS on preneoplastic + neoplastic lesions in mouse hepatocarcinogenesis. Foundational chemopreventive mechanism evidence. Subsequent studies: methanolic extract reduced corneal angiogenesis (Carneiro 2007 PMID 17481871); cytotoxic effects on MCF-7 human breast cancer cells (Nagamine 2008). Preclinical anticancer signal — HUMAN trials needed.
Mouse study (Freitas C et al. 2009, J Ethnopharmacol 122:468-472).
Mice receiving P. glomerata (closely related species) for pain modulation assessment. Glutamate + cytokine pathway analysis.
Antinociceptive effect involving GLUTAMATE + CYTOKINE pathways in mice. Foundational pain relief preclinical mechanism supporting traditional analgesic + anti-inflammatory tonic use. Distinguishing pain modulation dimension among adaptogens. HUMAN clinical evidence needed.
About this ingredient
PFAFFIA PANICULATA (Martius) Kuntze (recently renamed HEBANTHE ERIANTHA / HEBANTHE PANICULATA) is BRAZILIAN GINSENG / SUMA — Amaranthaceae family (NOT Araliaceae like true ginsengs). Endemic Brazilian medicinal plant. Brazilian folk medicine 'ANTI-STRESS' agent + TONIC + APHRODISIAC + MEMORY IMPROVEMENT. Active compounds: β-ECDYSTERONE (phytosteroid — supports anabolic + adaptogen activity), SAPONINS, PFAFFIC ACIDS, NORTRITERPENES, polysaccharides.
KEY EVIDENCE: COSTA C et al. 2015 PMID 26202807 (Int Immunopharmacol 28:459-469, UNESP Botucatu PhytoPharmaTech) — TNBS-induced intestinal inflammation rat study. 200 mg/kg significantly DECREASED macroscopic damage score, lesion extension, colonic MPO activity. 25 mg/kg decreased Hsp70. COSTA 2018 — modulates MAPK + mucin pathways. CANCER LETT 2005 226:107-113 — P. paniculata roots inhibitory effects on preneoplastic + neoplastic lesions in mouse hepatocarcinogenesis. CARNEIRO 2007 PMID 17481871 — methanolic extract reduces corneal angiogenesis (250-1000 mg/kg gavage 10 days, no weight loss or histopathological alterations). NAGAMINE 2008 — cytotoxic effects on MCF-7 human breast cancer cells. MATSUZAKI 2003 — 200 mg/kg reduced Ehrlich ascitic tumor volume via increased macrophage activity. FREITAS C et al. 2009 (J Ethnopharmacol 122:468-472) — antinociceptive effect via glutamate + cytokine pathways. β-ECDYSTERONE: induces osteogenic differentiation in MSCs + relieves osteoporosis (Gao); suppresses IL-1β-induced apoptosis + inflammation in chondrocytes via NF-κB inhibition (Zhang 2014).
MECHANISMS: β-ECDYSTERONE PHYTOSTEROID (anabolic + adaptogen, ER-β binding); MAPK + MUCIN PATHWAY intestinal regulation; NF-κB MMP-9 INHIBITION (anti-inflammatory); ANTINOCICEPTIVE glutamate + cytokine; MACROPHAGE ACTIVITY enhancement (Ehrlich tumor); HPA AXIS adaptogen multi-target. EVIDENCE: 2/5 reflects: (1) COSTA 2015 PMID 26202807 TNBS intestinal anti-inflammatory rat preclinical, (2) COSTA 2018 MAPK/mucin pathway preclinical mechanism, (3) Cancer Lett 2005 hepatocarcinogenesis preclinical chemopreventive, (4) FREITAS 2009 antinociceptive mouse mechanism, (5) β-ECDYSTERONE bioactive compound characterization, (6) BRAZILIAN folk medicine traditional use record (extensive in Amazonian/cerrado regions), (7) HONEST CRITICAL LIMITATION — WebMD 'no good scientific evidence' for cancer/diabetes/sexual performance/immune claims, (8) HONEST: studies on Pfaffia genera SCARCE compared to Panax/Eleutherococcus/Withania (well-documented adaptogens), (9) HUMAN CLINICAL TRIALS LIMITED — most evidence preclinical (rats, mice, cell lines), (10) lower-evidence than mainstream adaptogens due to limited Western human research. SAFETY: Generally favorable in traditional use BUT pregnancy/lactation contraindicated due to animal in utero/lactation testis function alterations (Auharek 2020). Best positioned as: (a) BRAZILIAN ADAPTOGEN ALTERNATIVE among 'ginseng' family (Panax + Eleutherococcus + Withania + Pfaffia), (b) STRESS + FATIGUE traditional support (Brazilian folk medicine), (c) APHRODISIAC + MEMORY traditional indications (limited human evidence), (d) GUT INFLAMMATION research candidate (Costa 2015 + 2018 preclinical), (e) β-ECDYSTERONE source for phytosteroid applications, (f) PREGNANCY/LACTATION: AVOID, (g) HORMONE-SENSITIVE conditions: theoretical caution, (h) AMARANTHACEAE allergies: caution, (i) LIMITED HUMAN evidence — position cautiously, (j) lower-evidence than mainstream adaptogens (Ashwagandha, Rhodiola, Holy Basil, Ginseng) due to clinical research gap. Honest framing: Pfaffia paniculata (Brazilian ginseng / Suma) has TRADITIONAL BRAZILIAN FOLK MEDICINE HERITAGE + emerging preclinical evidence — Costa 2015 + 2018 TNBS intestinal inflammation studies + Cancer Lett 2005 hepatocarcinogenesis + Freitas 2009 antinociceptive mechanism support adaptogen + anti-inflammatory + analgesic positioning. β-Ecdysterone is biochemically distinguishing among adaptogens — phytosteroid mechanism supporting potential anabolic + osteogenic + anti-inflammatory effects.
CRITICAL HONEST LIMITATION: per WebMD 'no good scientific evidence' for cancer/diabetes/male sexual performance/immune claims; studies on Pfaffia genera SCARCE compared to Panax/Eleutherococcus/Withania adaptogens with extensive clinical evidence base. MOST evidence preclinical (rats, mice, cell lines) — HUMAN clinical trials LIMITED. Pregnancy/lactation contraindication due to animal testis function alterations is important safety signal. Recently renamed to Hebanthe eriantha — distinguishing taxonomic update. Reasonable Brazilian adaptogen tonic for those wanting non-Asian heritage adaptogen — but evidence base substantially weaker than mainstream Asian adaptogens. Position as TRADITIONAL HERITAGE + EMERGING PRECLINICAL EVIDENCE rather than evidence-based first-line adaptogen recommendation.